4880 logo

CellSource Co., Ltd. Stock Price

TSE:4880 Community·JP¥7.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4880 Share Price Performance

JP¥390.00
-274.00 (-41.27%)
JP¥390.00
-274.00 (-41.27%)
Price JP¥390.00

4880 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

CellSource Co., Ltd. Key Details

JP¥3.7b

Revenue

JP¥1.6b

Cost of Revenue

JP¥2.1b

Gross Profit

JP¥2.0b

Other Expenses

JP¥89.1m

Earnings

Last Reported Earnings
Jan 31, 2026
Next Reporting Earnings
n/a
4.49
57.24%
2.39%
0%
View Full Analysis

About 4880

Founded
2015
Employees
148
CEO
Masayuki Yamakawa
WebsiteView website
www.cellsource.co.jp

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients’ adipose tissues, and to prepare platelet-rich plasma from patients’ blood; and offers support services for medical facilities providing regenerative medicine therapy. It is also involved in the sale of human stem cell-derived cosmetic ingredients; and Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Shibuya, Japan.

Recent 4880 News & Updates

Investors Appear Satisfied With CellSource Co., Ltd.'s (TSE:4880) Prospects

Dec 16
Investors Appear Satisfied With CellSource Co., Ltd.'s (TSE:4880) Prospects

Recent updates

No updates